Elanco Animal Health (ELAN) FY2021 results: revenue $4.8 billion, up 45.6% on the year
Elanco Animal Health Inc. (ELAN) reported revenue of $4.8 billion for fiscal 2021, the year ended 31 December 2021, up 45.6% on the year before. Net income was -$483 million, and diluted earnings per share $-0.99. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2022.
Revenue
$4.8 billion
+45.6% on the year
FY2016FY2021
Operating margin
-11.9%
-20.5% a year earlier
FY2016FY2021
Net income
-$483 million
FY2016FY2021
Diluted EPS
-$0.99
FY2016FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
483
-41.0
224
Capital expenditure
159
135
140
+17.8%
Free cash flow
324
-176
84.1
Free cash flow margin
6.8%
-5.4%
2.7%
Cash from investing
-530
-4,779
-235
Cash from financing
210
4,954
-305
-95.8%
Depreciation and amortisation
716
517
314
+38.5%
Share-based compensation
66.0
47.0
49.0
+40.4%
Diluted shares, weighted
487m
441m
370m
+10.4%
Shares outstanding at period end
473m
472m
373m
+0.3%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
7,508
8,457
5,547
-11.2%
Debt
6,319
6,127
2,355
+3.1%
Operating lease liabilities
127
151
61.7
-15.9%
Other liabilities
2,529
2,958
1,022
-14.5%
Total liabilities and equity
16,483
17,693
8,986
-6.8%
Fixed assets
1,055
1,316
955
-19.9%
Goodwill
6,172
6,225
2,990
-0.8%
Intangible assets
5,587
6,387
2,483
-12.5%
Cash and equivalents
638
495
334
+29.0%
Receivables
833
872
817
-4.4%
Inventory
1,373
1,578
1,051
-13.0%
Other assets
825
820
356
+0.6%
Total assets
16,483
17,693
8,986
-6.8%
10-K for the year ended 31 December 2021, filed 28 February 2022: the filing.